BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29168461)

  • 21. Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells.
    Andrade PZ; dos Santos F; Almeida-Porada G; da Silva CL; S Cabral JM
    Mol Biosyst; 2010 Jul; 6(7):1207-15. PubMed ID: 20424784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional nanofiber scaffolds with different spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/progenitor cells.
    Chua KN; Chai C; Lee PC; Ramakrishna S; Leong KW; Mao HQ
    Exp Hematol; 2007 May; 35(5):771-81. PubMed ID: 17577926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
    Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B
    Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates.
    Gori JL; Butler JM; Kunar B; Poulos MG; Ginsberg M; Nolan DJ; Norgaard ZK; Adair JE; Rafii S; Kiem HP
    Stem Cells Transl Med; 2017 Mar; 6(3):864-876. PubMed ID: 28297579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokines.
    Young JC; Lin K; Travis M; Hansteen G; Abitorabi A; Sirenko O; Murray L; Hill B
    Cytotherapy; 2001; 3(4):307-20. PubMed ID: 12171719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of human hematopoietic stem/progenitor cell migration by the extracellular matrix protein Slit3.
    Geutskens SB; Andrews WD; van Stalborch AM; Brussen K; Holtrop-de Haan SE; Parnavelas JG; Hordijk PL; van Hennik PB
    Lab Invest; 2012 Aug; 92(8):1129-39. PubMed ID: 22614124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.
    Levac K; Karanu F; Bhatia M
    Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CFU-megakaryocytic progenitors expanded ex vivo from cord blood maintain their in vitro homing potential and express matrix metalloproteinases.
    Shirvaikar N; Reca R; Jalili A; Marquez-Curtis L; Lee SF; Ratajczak MZ; Janowska-Wieczorek A
    Cytotherapy; 2008; 10(2):182-92. PubMed ID: 18368597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of mouse embryonic fibroblast cell lines that promote ex vivo expansion of human cord blood CD34+ hematopoietic progenitors.
    Qiu H; Fujimori Y; Kai S; Fujibayashi Y; Nishioka K; Hara H
    J Hematother Stem Cell Res; 2003 Feb; 12(1):39-46. PubMed ID: 12662435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic repopulating ability of CD34⁺ progenitor cells ex vivo expanded with different cytokine combinations.
    Du Z; Jin H; Cai H; Yang S; Tan WS
    Artif Cells Nanomed Biotechnol; 2015; 43(6):398-402. PubMed ID: 24665846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion and homing of umbilical cord blood hematopoietic stem and progenitor cells for clinical transplantation.
    Bari S; Seah KK; Poon Z; Cheung AM; Fan X; Ong SY; Li S; Koh LP; Hwang WY
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1008-19. PubMed ID: 25555449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex-vivo expansion of nonhuman primate CD34
    Shen B; Zhang Y; Dai W; Ma Y; Jiang Y
    Stem Cell Res Ther; 2016 Oct; 7(1):152. PubMed ID: 27765075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis.
    Yang M; Li K; Ng PC; Chuen CK; Lau TK; Cheng YS; Liu YS; Li CK; Yuen PM; James AE; Lee SM; Fok TF
    Stem Cells; 2007 Jul; 25(7):1800-6. PubMed ID: 17446559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
    Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
    Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of stromal cell-derived factor 1 and platelet factor 4 on the adhesion characteristics and chemotactic function of ex vivo expanded umbilical cord blood CD34+ cells].
    Li QC; Li YT; Meng HX; Wang YF; Wan CC; Li X; Ge W; Li Q; Han JL; Qiu LG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):83-8. PubMed ID: 16584598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproic acid affects the engraftment of TPO-expanded cord blood cells in NOD/SCID mice.
    Vulcano F; Milazzo L; Ciccarelli C; Barca A; Agostini F; Altieri I; Macioce G; Di Virgilio A; Screnci M; De Felice L; Giampaolo A; Hassan HJ
    Exp Cell Res; 2012 Feb; 318(4):400-7. PubMed ID: 22166516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell cycle activation of peripheral blood stem and progenitor cells expanded ex vivo with SCF, FLT-3 ligand, TPO, and IL-3 results in accelerated granulocyte recovery in a baboon model of autologous transplantation but G0/G1 and S/G2/M graft cell content does not correlate with transplantability.
    Drouet M; Herodin F; Norol F; Mourcin F; Mayol JF
    Stem Cells; 2001; 19(5):436-42. PubMed ID: 11553852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.